Bettina E. Hansen

1994–2026 年に発表

212
論文数
27,215
被引用数
94
h 指数
200
i10 指数

被引用数

Bettina E. Hansen の年別被引用数1996 年: 被引用 4 件1997 年: 被引用 7 件1998 年: 被引用 13 件1999 年: 被引用 18 件2000 年: 被引用 26 件2001 年: 被引用 23 件2002 年: 被引用 17 件2003 年: 被引用 15 件2004 年: 被引用 36 件2005 年: 被引用 48 件2006 年: 被引用 61 件2007 年: 被引用 68 件2008 年: 被引用 98 件2009 年: 被引用 87 件2010 年: 被引用 107 件2011 年: 被引用 144 件2012 年: 被引用 158 件2013 年: 被引用 139 件2014 年: 被引用 183 件2015 年: 被引用 256 件2016 年: 被引用 208 件2017 年: 被引用 263 件2018 年: 被引用 270 件2019 年: 被引用 837 件2020 年: 被引用 975 件2021 年: 被引用 981 件2022 年: 被引用 829 件2023 年: 被引用 602 件2024 年: 被引用 1,096 件2025 年: 被引用 557 件2026 年: 被引用 14 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,985 件、この内訳の 17.8%中国: 引用元論文 1,009 件、この内訳の 9%イギリス: 引用元論文 688 件、この内訳の 6.2%ドイツ: 引用元論文 636 件、この内訳の 5.7%イタリア: 引用元論文 633 件、この内訳の 5.7%カナダ: 引用元論文 582 件、この内訳の 5.2%フランス: 引用元論文 573 件、この内訳の 5.1%オランダ: 引用元論文 544 件、この内訳の 4.9%スペイン: 引用元論文 369 件、この内訳の 3.3%日本: 引用元論文 320 件、この内訳の 2.9%オーストラリア: 引用元論文 290 件、この内訳の 2.6%韓国: 引用元論文 286 件、この内訳の 2.5%
0%17.8%その他 29.1%

分野

  • Medicine86.9%
  • Biochemistry, Genetics and Molecular Biology7%
  • Immunology and Microbiology3.4%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Computer Science0.3%
  • Engineering0.3%
  • その他1.4%

トピック

  • Liver Disease Diagnosis and Treatment12.8%
  • Hepatitis C virus research10.3%
  • Hepatitis B Virus Studies8.7%
  • Liver Diseases and Immunity5.5%
  • Liver Disease and Transplantation4.6%
  • Hepatocellular Carcinoma Treatment and Prognosis3.4%
  • その他54.7%

共著者

全論文

検索で開く
  1. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Pruzanski, Д. А. Шапиро - New England Journal of Medicine 2016 被引用: 1,108

  2. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2024 被引用: 159

  3. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg - Gastroenterology 2017 被引用: 523

  4. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2015 被引用: 541

  5. Early Treatment with Pegylated Interferon Lambda for Covid-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher Kandel, Mia J. Biondi, Robert Kozak, Bettina E. Hansen, Muhammad Atif Zahoor, Paul Arora, Colin Hislop, Ingrid Choong, Jordan J. Feld, Edward J. Mills, Jeffrey S. Glenn - New England Journal of Medicine 2023 被引用: 174

  6. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2014 被引用: 489

  7. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 被引用: 436

  8. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 被引用: 277

  9. External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

    著者: , , , , , - Clinical Gastroenterology and Hepatology 2013 被引用: 343

  10. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook ほか 56 名 - Gastroenterology 2022 被引用: 101

  11. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

    著者: , , , , - Journal of Hepatology 2015 被引用: 495

  12. Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study

    著者: , , , , , - The Lancet Respiratory Medicine 2020 被引用: 223

  13. Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B

    著者: , , , , , , , - Hepatology 2019 被引用: 208

  14. Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 被引用: 187

  15. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis

    著者: , , , , , , , , - Journal of Hepatology 2021 被引用: 136

  16. Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

    著者: , , , , , , , , , - Gastroenterology 2009 被引用: 460

  17. Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis

    著者: , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2020 被引用: 138

  18. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

    著者: , , , , , , , , - JHEP Reports 2021 被引用: 114

  19. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 171

  20. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

    著者: , , , , , , , , , , - Gut 2013 被引用: 265

  21. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Lorne Tyrrell, Jeffrey S. Glenn, Adam J. Gehring, Harry L.A. Janssen, Bettina E. Hansen - The Lancet Respiratory Medicine 2021 被引用: 237

  22. Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

    著者: , , , , , , , , , , , , , - Journal of Hepatology 2017 被引用: 213

  23. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity

    著者: , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 141

  24. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2019 被引用: 116